Poor gut health may drive multiple sclerosis—better diet may ease it

by Rutgers UniversityDevelopment of colitis in spontaneous EAE mice. (A) Swollen colon in spontaneous EAE mice. (B) H&E histopathology of swollen colon isolated from spontaneous EAE and non-E

Updated on: February 03,2024

Poor gut health may drive multiple sclerosis—better diet may ease it

by Rutgers UniversityDevelopment of colitis in spontaneous EAE mice. (A) Swollen colon in spontaneous EAE mice. (B) H&E histopathology of swollen colon isolated from spontaneous EAE and non-E

Updated on:February 03,2024

Asymmetrical neuron loss in Alzheimer's

by Ludwig Maximilian University of MunichCredit: Christian Wachinger/LMUAs Alzheimer's disease progresses, neuron loss leads to marked lateral asymmetries in brain structure. A new LMU study

Updated on: March 09,2024

Asymmetrical neuron loss in Alzheimer's

by Ludwig Maximilian University of MunichCredit: Christian Wachinger/LMUAs Alzheimer's disease progresses, neuron loss leads to marked lateral asymmetries in brain structure. A new LMU study

Updated on:March 09,2024

Alzheimer's: Can an amino acid help to restore memories?

by CNRSCredit: Laboratoire des maladies neurodégénératives (CNRS/CEA/Université Paris Saclay)Scientists at the Laboratoire des Maladies Neurodégénératives (CNRS/CEA/Université Paris-Saclay) and t

Updated on: March 09,2024

Alzheimer's: Can an amino acid help to restore memories?

by CNRSCredit: Laboratoire des maladies neurodégénératives (CNRS/CEA/Université Paris Saclay)Scientists at the Laboratoire des Maladies Neurodégénératives (CNRS/CEA/Université Paris-Saclay) and t

Updated on:March 09,2024

Drop in mortality seen with AChEI, memantine in dementia with lewy bodies

by Elana GotkineFor patients with dementia with Lewy bodies (DLB), treatment with acetylcholinesterase inhibitors (AChEIs) and/or memantine is associated with reduced hospital admissions and mortality

Updated on: June 24,2024

Drop in mortality seen with AChEI, memantine in dementia with lewy bodies

by Elana GotkineFor patients with dementia with Lewy bodies (DLB), treatment with acetylcholinesterase inhibitors (AChEIs) and/or memantine is associated with reduced hospital admissions and mortality

Updated on:June 24,2024

The construction of visual attention highlighted at the neuronal level

byParis Brain InstituteAttention being caught. Credit: Mikhail Nilov.A giant billboard flashes on the side of a country road. Why does it catch our attention more easily than other details in th

Updated on: March 28,2024

The construction of visual attention highlighted at the neuronal level

byParis Brain InstituteAttention being caught. Credit: Mikhail Nilov.A giant billboard flashes on the side of a country road. Why does it catch our attention more easily than other details in th

Updated on:March 28,2024

Brain cell membranes' lipids may play big role in Alzheimer's progression

by American Institute of PhysicsLinks between lipid imbalance and disease have been established, in which lipid changes increase the formation of amyloid plaques, a hallmark of Alzheimer's di

Updated on: May 18,2024

Brain cell membranes' lipids may play big role in Alzheimer's progression

by American Institute of PhysicsLinks between lipid imbalance and disease have been established, in which lipid changes increase the formation of amyloid plaques, a hallmark of Alzheimer's di

Updated on:May 18,2024

The orchid and dandelion phenomenon in brain aging: Personalizing cognitive health approaches for older adults

Updated on: September 05,2024

The orchid and dandelion phenomenon in brain aging: Personalizing cognitive health approaches for older adults

Updated on:September 05,2024

Yeast protein could offer clues to how Alzheimer's plaques form in the brain

by Anne Trafton,Massachusetts Institute of TechnologyMIT biologists found that the yeast protein Rim4 forms disordered clumps similar to the beta-amyloid plaques associated with Alzheimer’s dise

Updated on: February 26,2024

Yeast protein could offer clues to how Alzheimer's plaques form in the brain

by Anne Trafton,Massachusetts Institute of TechnologyMIT biologists found that the yeast protein Rim4 forms disordered clumps similar to the beta-amyloid plaques associated with Alzheimer’s dise

Updated on:February 26,2024

Certain genetic variant in Alzheimer's disease linked to African ancestry

by Elana GotkineFor individuals of African ancestry, theAPOEε3 R145C missense variant is associated with an increased risk for Alzheimer disease (AD), according to a study published in the

Updated on: April 25,2024

Certain genetic variant in Alzheimer's disease linked to African ancestry

by Elana GotkineFor individuals of African ancestry, theAPOEε3 R145C missense variant is associated with an increased risk for Alzheimer disease (AD), according to a study published in the

Updated on:April 25,2024

Detecting diminished dopamine-firing cells inside brain could reveal earliest signs of Alzheimer's

by University of SheffieldPET scan of a human brain with Alzheimer's disease. Credit: public domainA new link between diminished input from dopamine-firing cells deep inside the brain and the

Updated on: June 20,2024

Detecting diminished dopamine-firing cells inside brain could reveal earliest signs of Alzheimer's

by University of SheffieldPET scan of a human brain with Alzheimer's disease. Credit: public domainA new link between diminished input from dopamine-firing cells deep inside the brain and the

Updated on:June 20,2024

GluN3A knockout mouse: Alternative model for Alzheimer's neurodegeneration

by Emory UniversityGluN3A (in the diagram, NR3) is an inhibitory subunit within NMDA receptor assemblies, which function as glutamate-gated cation channels. GluN3A is a key regulator of neuronal

Updated on: March 30,2024

GluN3A knockout mouse: Alternative model for Alzheimer's neurodegeneration

by Emory UniversityGluN3A (in the diagram, NR3) is an inhibitory subunit within NMDA receptor assemblies, which function as glutamate-gated cation channels. GluN3A is a key regulator of neuronal

Updated on:March 30,2024

No new drugs for Alzheimer's disease in 15 years

by Vanessa Jane Hall,ScienceNordicCredit: AI-generated imageHow often to you read headlines proclaiming the arrival of a new, ground-breaking treatment for Alzheimer's?The answer is probably

Updated on: March 13,2024

No new drugs for Alzheimer's disease in 15 years

by Vanessa Jane Hall,ScienceNordicCredit: AI-generated imageHow often to you read headlines proclaiming the arrival of a new, ground-breaking treatment for Alzheimer's?The answer is probably

Updated on:March 13,2024